Dr. Gabriel N. Dikong
Founder and Chairman of CMFIT Global Group Corp.
Dr. Gabriel N. Dikong is a Senior Clinical Research Specialist, healthcare executive, U.S. Air Force veteran, author, and public health professional with more than 14 years of experience across clinical trials, pharmaceuticals, biotechnology, medical devices, and clinical operations.
Born in Douala, Cameroon, Dr. Dikong moved to the United States in 2002 and served in the U.S. Air Force from 2004 to 2007. His expertise spans from his clinical trial operations, regulatory compliance, quality improvement, data analysis, patient safety, and medical device research.
Dr. Dikong serves as CEO and Chairman of CMFIT Global Health Consulting and CGHC Clinic, and as Founder and Chairman of CMFIT Global Group Corp., with interests spanning healthcare, research, technology, philanthropy through Charity Medical Foundation & IT Inc., media, transportation, and advanced technology.
He holds a Doctor of Public Health from Walden University’s School of Health Sciences, Duo Master of Sciences in Biostatistics and Epidemiology, and Postgraduate degree in Biomedical Informatics both at the University of Cincinnati College of Medicine. His credentials include Certified Clinical Research Associate (CCRA), Certified Health Education Specialist (CHES), and Certified in Public Health (CPH).
Dr. Dikong has contributed to scholarly work in cancer epidemiology, biostatistics, and biomedical science. He is the author of A Geographic Study of Lung and Bronchi Cancer Rates in the State of Kentucky, a novel scientific work that can be found in the U.S. Library of Congress in Washington, D.C. His forthcoming books include The Golden Equations of Life, The Landscape of AI in Genome and Precision Medicine, and Rising – From Detour to Destiny: The True Story of Dr. Gabriel N. Dikong.
As a contributor to The Better Voice, he brings an evidence-based perspective on healthcare, clinical research, public health, scientific innovation, and technology’s evolving role in improving health outcomes worldwide.
